FGFR2 GENE ACTIVATION

Clinical trials for FGFR2 GENE ACTIVATION explained in plain language.

Never miss a new study

Get alerted when new FGFR2 GENE ACTIVATION trials appear

Sign up with your email to follow new studies for FGFR2 GENE ACTIVATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New precision drug targets genetic driver in tough cancers

Disease control Completed

This study tested a new, highly targeted drug called RLY-4008 in people with advanced cancers, focusing on bile duct cancer. The main goals were to find a safe and effective dose and to see if the drug could shrink tumors in patients whose cancers have a specific genetic change c…

Matched conditions: FGFR2 GENE ACTIVATION

Phase: PHASE1, PHASE2 • Sponsor: Elevar Therapeutics • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

FGFR2 GENE ACTIVATION

Get alerted when new FGFR2 GENE ACTIVATION trials appear

New precision drug targets genetic driver in tough cancers